The Prevalence and Clinical Significance of Anti-U1 RNA Antibodies in Patients with Systemic Scleros...
The Prevalence and Clinical Significance of Anti-U1 RNA Antibodies in Patients with Systemic Sclerosis
About this item
Full title
Author / Creator
Publisher
Danvers, MA: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Danvers, MA: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
We studied the prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis. The presence of anti-U1 RNA antibodies was determined using immunoprecipitation in systemic sclerosis patients with anti-U1 RNP antibodies (n=36), antitopoisomerase I antibodies (n=20), or anticentromere antibodies (n=20), mixed connec...
Alternative Titles
Full title
The Prevalence and Clinical Significance of Anti-U1 RNA Antibodies in Patients with Systemic Sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72972093
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72972093
Other Identifiers
ISSN
0022-202X
E-ISSN
1523-1747
DOI
10.1046/j.1523-1747.2003.12028.x
